497 related articles for article (PubMed ID: 6972829)
1. The metabolic consequences of blood and crystalloid cardioplegia.
Engelman RM; Rousou JH; Lemeshow S; Dobbs WA
Circulation; 1981 Aug; 64(2 Pt 2):II67-74. PubMed ID: 6972829
[TBL] [Abstract][Full Text] [Related]
2. High-volume crystalloid cardioplegia. An improved method of myocardial preservation.
Engelman RM; Rousou JH; Lemeshow S
J Thorac Cardiovasc Surg; 1983 Jul; 86(1):87-96. PubMed ID: 6602916
[TBL] [Abstract][Full Text] [Related]
3. The effect of temperature and hematocrit level of oxygenated cardioplegic solutions on myocardial preservation.
Rousou JA; Engelman RM; Breyer RH; Otani H; Lemeshow S; Das DK
J Thorac Cardiovasc Surg; 1988 Apr; 95(4):625-30. PubMed ID: 3352296
[TBL] [Abstract][Full Text] [Related]
4. Protection of the hypertrophied pig myocardium. A comparison of crystalloid, blood, and Fluosol-DA cardioplegia during prolonged aortic clamping.
Novick RJ; Stefaniszyn HJ; Michel RP; Burdon FD; Salerno TA
J Thorac Cardiovasc Surg; 1985 Apr; 89(4):547-66. PubMed ID: 3157028
[TBL] [Abstract][Full Text] [Related]
5. Superiority of perfluorocarbon cardioplegia over blood or crystalloid cardioplegia.
Kanter KR; Jaffin JH; Ehrlichman RJ; Flaherty JT; Gott VL; Gardner TJ
Circulation; 1981 Aug; 64(2 Pt 2):II75-80. PubMed ID: 7249332
[TBL] [Abstract][Full Text] [Related]
6. A clinical comparison of potassium and magnesium-potassium crystalloid cardioplegia: metabolic considerations.
Engelman RM; Rousou JH; Lemeshow S; Dobbs WA
J Cardiovasc Surg (Torino); 1985; 26(4):343-50. PubMed ID: 3874871
[TBL] [Abstract][Full Text] [Related]
7. Myocardial metabolism and ventricular function following cold potassium cardioplegia.
Fremes SE; Weisel RD; Mickle DA; Ivanov J; Madonik MM; Seawright SJ; Houle S; McLaughlin PR; Baird RJ
J Thorac Cardiovasc Surg; 1985 Apr; 89(4):531-46. PubMed ID: 3872382
[TBL] [Abstract][Full Text] [Related]
8. Enhanced myocardial protection during ischemic arrest. Oxygenation of a crystalloid cardioplegic solution.
Bodenhamer RM; DeBoer LW; Geffin GA; O'Keefe DD; Fallon JT; Aretz TH; Haas GS; Daggett WM
J Thorac Cardiovasc Surg; 1983 May; 85(5):769-80. PubMed ID: 6843158
[TBL] [Abstract][Full Text] [Related]
9. Myocardial oxygen tension during surgical revascularization. A clinical comparison between blood cardioplegia and crystalloid cardioplegia.
Bjerrum JT; Perko MJ; Beck B
Eur J Cardiothorac Surg; 2006 Feb; 29(2):181-5. PubMed ID: 16387508
[TBL] [Abstract][Full Text] [Related]
10. Myocardial protection during prolonged aortic cross-clamping. Comparison of blood and crystalloid cardioplegia.
Catinella FP; Cunningham JN; Spencer FC
J Thorac Cardiovasc Surg; 1984 Sep; 88(3):411-23. PubMed ID: 6471891
[TBL] [Abstract][Full Text] [Related]
11. Antegrade versus retrograde crystalloid cardioplegia: perioperative assessment of cardiac energy metabolism by means of myocardial lactate measurement.
Noyez L; Verhagen AF; Lacquet LK
Thorac Cardiovasc Surg; 1995 Aug; 43(4):194-9. PubMed ID: 7502281
[TBL] [Abstract][Full Text] [Related]
12. Fluosol cardioplegia--a method of optimizing aerobic metabolism during arrest.
Rousou JH; Dobbs WA; Engelman RM
Circulation; 1982 Aug; 66(2 Pt 2):I55-9. PubMed ID: 7083547
[TBL] [Abstract][Full Text] [Related]
13. Does retrograde administration of blood cardioplegia improve myocardial protection during first operation for coronary artery bypass grafting?
Carrier M; Pelletier LC; Searle NR
Ann Thorac Surg; 1997 Nov; 64(5):1256-61; discussion 1262. PubMed ID: 9386688
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the effect of blood cardioplegia to crystalloid cardioplegia on myocardial contractility in man.
Shapira N; Kirsh M; Jochim K; Behrendt DM
J Thorac Cardiovasc Surg; 1980 Nov; 80(5):647-55. PubMed ID: 6968855
[TBL] [Abstract][Full Text] [Related]
15. Multidose blood versus crystalloid cardioplegia. Comparison by quantitative assessment of irreversible myocardial injury.
Feindel CM; Tait GA; Wilson GJ; Klement P; MacGregor DC
J Thorac Cardiovasc Surg; 1984 Apr; 87(4):585-95. PubMed ID: 6708578
[TBL] [Abstract][Full Text] [Related]
16. Effect of an oxygen-enriched solution and multiple dosing of antegrade crystalloid cardioplegic solution on myocardial metabolism during coronary artery bypass graft operations.
Downey RS; Weintraub WS; Jones EL; Conn RB; Ash T
J Thorac Cardiovasc Surg; 1992 Oct; 104(4):1148-7. PubMed ID: 1405675
[TBL] [Abstract][Full Text] [Related]
17. Studies of controlled reperfusion after ischemia. XX. Reperfusate composition: detrimental effects of initial asanguineous cardioplegic washout after acute coronary occlusion.
Acar C; Partington MT; Buckberg GD
J Thorac Cardiovasc Surg; 1991 Feb; 101(2):294-302. PubMed ID: 1992240
[TBL] [Abstract][Full Text] [Related]
18. Changing patterns of patients undergoing emergency surgical revascularization for acute coronary occlusion. Importance of myocardial protection techniques.
Beyersdorf F; Mitrev Z; Sarai K; Eckel L; Klepzig H; Maul FD; Ihnken K; Satter P
J Thorac Cardiovasc Surg; 1993 Jul; 106(1):137-48. PubMed ID: 8320992
[TBL] [Abstract][Full Text] [Related]
19. [Myocardial metabolism during coronary perfusion at 10 degrees C with or without cardioplegia associated with potassium].
Mikaeloff P; Amouroux C; Boivin J; Guidollet J; Vial C; El Kirat M
Arch Mal Coeur Vaiss; 1980 Sep; 73(9):1075-85. PubMed ID: 6776926
[TBL] [Abstract][Full Text] [Related]
20. Effects of crystalloid and blood cardioplegic solutions on myocardial cooling during myocardial revascularization.
Landymore RW; Kinley CE
Can J Surg; 1984 May; 27(3):257-9. PubMed ID: 6609757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
